Results 301 to 310 of about 106,447 (316)

PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC

Signal Transduction and Targeted Therapy, 2020
Xunbin Wei, Shengyu Yang, Jihui Hao
exaly  

Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression

Nature, 2007
Yisong Y Wan
exaly  

Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells

Nature, 2007
Ye Zheng, Steven Z Josefowicz, Alexander Y Rudensky   +2 more
exaly  

Foxp3 occupancy and regulation of key target genes during T-cell stimulation

Nature, 2007
Alexander Marson, Karsten Kretschmer, Garrett M Frampton   +2 more
exaly  

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

Nature Medicine, 2007
Olivier P Joffre, Denis Hudrisier
exaly  

A function for interleukin 2 in Foxp3-expressing regulatory T cells

Nature Immunology, 2005
Marc A Gavin, Alexander Y Rudensky
exaly  

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

Nature Immunology, 2008
Qizhi Tang, Jeffrey A Bluestone
exaly  

Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells

Nature Reviews Drug Discovery, 2009
Liqing Wang, Wayne W Hancock
exaly  

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells

Nature Immunology, 2007
Pushpa Pandiyan, Lixin Zheng, Michael J Lenardo   +2 more
exaly  

A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3

Nature Immunology, 2005
Alexander Y Rudensky
exaly